Skip to main content
. 2023 Jun 3;22:101330. doi: 10.1016/j.cegh.2023.101330

Table 3.

Vaccinations provided to participants (N = 172).

First dose N(%) Second dose N(%) Third dose (Booster) N(%)
Pfizer-BioNTech's 91(52.9) Pfizer-BioNTech's 91(52.9) Pfizer-BioNTech's 51(29.7)
Sputnik V 50(29.1) Sputnik V 50(29.1)
Sinovac 10(5.8) Sinovac 10(5.8)
Sputnik light 14(8.2)
Moderna 4(2.3) Moderna 4(2.3)
AstraZeneca 3(1.7) AstraZeneca 3(1.7)
Total 172(100) 158(91.8) 51(29.7)